DR. ALAN MAISEL, MD
Osteopathic Medicine at La Jolla Village Dr, San Diego, CA
License number
California G46900
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
2
3350 La Jolla Village Dr, San Diego, CA 92161
190 Del Mar Shores Ter UNIT 35, Solana Beach, CA 92075
190 Del Mar Shores Ter UNIT 35, Solana Beach, CA 92075
Phone
(858) 552-8585
(858) 449-9912
(858) 449-9912
Personal information
See more information about ALAN MAISEL at radaris.comName
Address
Phone
14929 Via La Senda, Del Mar, CA 92014
14929 Via La Senda, Solana Beach, CA 92014
14929 Via La Senda, Del Mar, CA 92014
190 Del Mar Shores Ter #35, Solana Beach, CA 92075
774 Sierra Ave, Solana Beach, CA 92075
Organization information
See more information about ALAN MAISEL at bizstanding.comVa Medical Ctr-San Diego - Bard C Cosman MD
3350 Ln Jolla Vlg Dr #112, San Diego, CA 92161
Doing business as:
Va Medical Ctr-San Diego - Alan Maisel MD<br>Va Medical Ctr-San Diego - Dewleen G Baker MD<br>Va Medical Ctr-San Diego - Inigo A Garcia-Zozaya MD
Phone:
(858) 552-8585 (Phone)
Categories:
Proctology Physicians & Surgeons, Cardiology Physicians & Surgeons, Psychiatry Physicians, ...
Alan Maisel MD
3350 Ln Jolla Vlg Dr, San Diego, CA 92161
Industry:
Cardiologist, Internist
Phone:
(858) 552-8585 (Phone)
Alan Stewart Maisel
Professional information
Dr. Alan Maisel, San Diego CA - MD (Doctor of Medicine)
Specialties:
Cardiology
Address:
VA Medical Ctr San Diego Cadio
3350 La Jolla Village Dr, San Diego 92161
(858) 552-8585 (Phone)
3350 La Jolla Village Dr, San Diego 92161
(858) 552-8585 (Phone)
Procedures:
Cardiac Imaging
Conditions:
Angina and Acute Coronary Syndrome, Aortic Ectasia, Aortic Valve Disease, Arrhythmias (incl. Atrial Fibrillation), Cardiomegaly, Cardiomyopathy, Congestive Heart Failure, Coronary Artery Disease (CAD), Endocarditis, Hyperlipidemia, Hypertension, Hypotension, Mitral Valve Disease, Pericardial Disease, Pulmonary Hypertension, Syncope, Tricuspid Valve Disease
Certifications:
Cardiovascular Disease, 1985, Internal Medicine, 1981
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
VA Medical Ctr San Diego Cadio
3350 La Jolla Village Dr, San Diego 92161
Pomerado Hospital
15615 Pomerado Rd, Poway 92064
3350 La Jolla Village Dr, San Diego 92161
Pomerado Hospital
15615 Pomerado Rd, Poway 92064
Education:
Medical School
University of Mi Med Sch
Graduated: 1978
Michael Reese Hospital and Medical Center
University Of California, San Diego
University of Mi Med Sch
Graduated: 1978
Michael Reese Hospital and Medical Center
University Of California, San Diego
Alan Stewart Maisel, San Diego CA
Specialties:
Cardiologist
Address:
3350 La Jolla Village Dr, San Diego, CA 92161
Education:
University of Michigan, Medical School - Doctor of Medicine
UCSD Healthcare - Fellowship - Cardiology
Michael Reese Hospital - Residency - Internal Medicine
UCSD Healthcare - Fellowship - Cardiology
Michael Reese Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine)
Owner, Va
Position:
Owner at va
Location:
Greater San Diego Area
Industry:
Medical Practice
Work:
va
-
Owner
Alan Stewart Maisel, San Diego CA
Specialties:
Internal Medicine, Cardiovascular Disease, Cardiology
Work:
Va San Diego Healthcare System
3350 La Jolla Village Dr, San Diego, CA 92161
3350 La Jolla Village Dr, San Diego, CA 92161
Education:
University of Michigan Medical School (1978)
Methods And Compositions For Treatment Of Ischemic Conditions And Conditions Related To Mitochondrial Function
US Patent:
2012009, Apr 19, 2012
Filed:
Apr 17, 2010
Appl. No.:
13/264935
Inventors:
Francisco Villareal - Chula Vista CA, US
Pam R. Taub - Rancho Santa Fe CA, US
Alan S. Maisel - Solana Beach CA, US
George F. Schreiner - Los Altos Hills CA, US
Anne Murphy - Encinitas CA, US
Katrina Yamazaki - Diamond Bar CA, US
Guillermo Ceballos - Lindavista, MX
Pam R. Taub - Rancho Santa Fe CA, US
Alan S. Maisel - Solana Beach CA, US
George F. Schreiner - Los Altos Hills CA, US
Anne Murphy - Encinitas CA, US
Katrina Yamazaki - Diamond Bar CA, US
Guillermo Ceballos - Lindavista, MX
International Classification:
A61K 31/353, A61P 3/00, A61P 9/12, A61P 13/12, A61P 7/00, A61P 9/04, A61P 3/04, A61P 5/48, A61P 21/00, A61K 31/4406, A61P 25/28
US Classification:
514355, 514456
Abstract:
The present invention relates to compositions and methods for prophylactic and/or therapeutic treatment of conditions related to mitochondrial function. In various aspects, the present invention comprises administering one or more compounds selected from the group consisting of epicatechin, an epicatechin derivative, catechin, a catechin derivative, nicorandil, and a nicorandil derivative in an amount effective to stimulate mitochondrial function in cells. The methods and compositions described herein provide for reducing infarct size in the heart following permanent ischemia or ischemia/reperfusion (IR) event or method for delaying, attenuating or preventing adverse cardiac remodeling, and can assist in prevention of impaired mitochondria biogenesis and thus prevention of the consequences of impaired mitochondrial biogenesis in various diseases and conditions, as well as provide for the active therapy of mitochondrial depletion that may have already occurred.
Use Of Thrombus Precursor Protein And Monocyte Chemoattractant Protein As Diagnostic And Prognostic Indicators In Vascular Diseases
US Patent:
2004020, Oct 14, 2004
Filed:
Dec 3, 2003
Appl. No.:
10/728067
Inventors:
Kenneth Buechler - Rancho Santa Fe CA, US
Alan Maisel - Solana Beach CA, US
Alan Maisel - Solana Beach CA, US
Assignee:
Biosite, Inc.
International Classification:
G01N033/53, G01N033/537, G01N033/543
US Classification:
435/007920
Abstract:
The present invention relates to methods for the diagnosis and evaluation of acute coronary syndromes. In particular, patient test samples are analyzed for the presence and amount of members of a panel of markers comprising one or more specific markers for myocardial injury and one or more non-specific markers for myocardial injury. A variety of markers are disclosed for assembling a panel of markers for such diagnosis and evaluation. In various aspects, the invention provides methods for the early detection and differentiation of stable angina, unstable angina, and myocardial infarction. Invention methods provide rapid, sensitive and specific assays that can greatly increase the number of patients that can receive beneficial treatment and therapy, reduce the costs associated with incorrect diagnosis, and provide important information about the prognosis of the patient.
Use Of Epicatechin And Derivatives And Salts Thereof For Cardiac Protection Of Ischemic Myocardium And To Ameliorate Adverse Cardiac Remodeling
US Patent:
8648059, Feb 11, 2014
Filed:
Mar 12, 2009
Appl. No.:
12/922170
Inventors:
Francisco Villarreal - Chula Vista CA, US
Katrina Go Yamazaki - La Jolla CA, US
Pam Rajendran Taub - San Diego CA, US
Alan Maisel - Solana Beach CA, US
Katrina Go Yamazaki - La Jolla CA, US
Pam Rajendran Taub - San Diego CA, US
Alan Maisel - Solana Beach CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/65
US Classification:
514152, 514154
Abstract:
The disclosure provides a method of reducing infarct size in the heart following permanent ischemia or ischemia/reperfusion (IR) event or method for delaying, attenuating or preventing adverse cardiac remodeling comprising administering a drug selected from the group consisting of epicatechin, derivatives thereof and pharmaceutically acceptable salts thereof, wherein the subject is a human or a veterinary animal. Additionally the disclosure provides a method of treating subarachnoid hemorrhage or atrial fibrillation or of enhancing or preserving migration, seeding, proliferation, differentiation and/or survival of stem cells in injured heart tissue comprising administering a drug selected from the group consisting of epicatechin, derivatives thereof and pharmaceutically acceptable salts thereof. The effects of epicatechin administration are sustained over time.
Methods And Compositions For Treatment Of Mitochondrial Toxicity
US Patent:
2013017, Jul 4, 2013
Filed:
Jun 5, 2012
Appl. No.:
13/489317
Inventors:
Francisco Villarreal - Chula Vista CA, US
Alan Maisel - Solana Beach CA, US
George Schreiner - Los Altos Hills CA, US
Guillermo M. Ceballos Reyes - Medico D.F., MX
Pam Taub - Rancho Santa Fe CA, US
Alan Maisel - Solana Beach CA, US
George Schreiner - Los Altos Hills CA, US
Guillermo M. Ceballos Reyes - Medico D.F., MX
Pam Taub - Rancho Santa Fe CA, US
International Classification:
A61K 31/455, A61K 31/573, A61K 45/06, A61K 31/353
US Classification:
424649, 514456, 514355, 514220, 51425941, 51421113, 514 50, 514330, 514369, 514 34, 514350, 514158, 514420, 5142265, 514342, 514354, 514274, 514 49, 51425405, 5142634, 514 45, 51425407, 514 81, 514 40, 514 205, 514110, 514171
Abstract:
The present invention relates to compositions and methods for prophylactic and/or therapeutic treatment of conditions related to mitochondrial function. In various aspects, the present invention comprises administering one or more compounds selected from the group consisting of epicatechin, an epicatechin derivative, catechin, a catechin derivative, nicorandil, and a nicorandil derivative in an amount effective to ameliorate mitochondrial toxicity caused by administration of a chemical, food, or drug.